Announcements Trials
Browse Landscape

Status

Recruiting 2Unknown 1Completed 1

Sponsor Class

OTHER 4

Study Type

Observational 4Interventional 4

Sponsor

Cancer Type

Myeloid 4

Conditions

Breast Neoplasms 2936Neoplasms 2634Lung Neoplasms 1371Colorectal Neoplasms 1332Prostatic Neoplasms 1216Carcinoma, Non-Small-Cell Lung 1080Carcinoma, Hepatocellular 784Stomach Neoplasms 721Pancreatic Neoplasms 704Ovarian Neoplasms 586Colonic Neoplasms 534Uterine Cervical Neoplasms 497Head and Neck Neoplasms 496Rectal Neoplasms 472Melanoma 467Multiple Myeloma 463Esophageal Neoplasms 423Neoplasm Metastasis 418Brain Neoplasms 405Lymphoma 399Precursor Cell Lymphoblastic Leukemia-Lymphoma 398Urinary Bladder Neoplasms 387Leukemia, Myeloid, Acute 387Leukemia 339Carcinoma, Renal Cell 329Liver Neoplasms 320Endometrial Neoplasms 319Hematologic Neoplasms 313Recurrence 298Disease 275

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Observational × Mast Cell Activation Disorders × Clear all
NCT06186856 2026-04-22

DATAMAST

Imagine Institute

Recruiting
13,000 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT06466889 2024-06-26

MastoR

University of Zurich

Recruiting
400 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT04615663 2020-11-04

MCD&BuDi

University Hospital, Toulouse

Unknown
200 enrolled
Myeloid

Mast Cell Activation Disorders, Mastocytosis

NCT00336076 2016-11-07

Molecular Mechanisms and Diagnosis of Mastocytosis

University of Michigan

Completed
136 enrolled
Myeloid

Mast Cell Activation Disorders, Anaphylaxis, Mastocytosis, Piebaldism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡